Corporate information
Registration country
Company type
A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need.Funding rounds
Acquisition USD 3,500,000,000
USD 3,500,000,000 ( ) at USD 3,500,000,000 pre-money valuation
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Otsuka Pharmaceutical | USD 3,500,000,000 (USD 3,500,000,000) Initial investment. Led the round. |
Debt
( )
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Oxford Finance LLC | Provider of capital exclusively to life sciences and healthcare services companies worldwide. | Initial investment. |
N/A
( )
Investor | Profile | Country | |
---|---|---|---|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
Investment activity status
Active investor